These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 7545083)

  • 1. Palliation of bone pain in patients with metastatic cancer using strontium-89 (Metastron).
    Kan MK
    Cancer Nurs; 1995 Aug; 18(4):286-91. PubMed ID: 7545083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone pain palliation with 85Sr therapy.
    Giammarile F; Mognetti T; Blondet C; Desuzinges C; Chauvot P
    J Nucl Med; 1999 Apr; 40(4):585-90. PubMed ID: 10210217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Strontium-89 as an adjuvant to external beam radiation improves pain relief and delays disease progression in advanced prostate cancer: results of a randomized controlled trial.
    Porter AT; McEwan AJ
    Semin Oncol; 1993 Jun; 20(3 Suppl 2):38-43. PubMed ID: 7684865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Strontium-89 (Metastron) in the treatment of prostate cancer metastatic to bone.
    Porter AT
    Eur Urol; 1994; 26 Suppl 1():20-5. PubMed ID: 7537665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Strontium 89 therapy for the palliation of pain due to osseous metastases.
    Robinson RG; Preston DF; Schiefelbein M; Baxter KG
    JAMA; 1995 Aug; 274(5):420-4. PubMed ID: 7542352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of strontium-89 palliative therapy in patients with painful bone metastases.
    Zorga P; Birkenfeld B; Listewnik MH; Piwowarska-Bilska H
    Ann Acad Med Stetin; 2011; 57(1):49-53; discussion 53. PubMed ID: 22593991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic radionuclide therapy of bone metastases with strontium-89.
    Porter AT; Davis LP
    Oncology (Williston Park); 1994 Feb; 8(2):93-6; discussion 96, 99-101. PubMed ID: 8167090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strontium chloride Sr 89 for treating pain from metastatic bone disease.
    Nightengale B; Brune M; Blizzard SP; Ashley-Johnson M; Slan S
    Am J Health Syst Pharm; 1995 Oct; 52(20):2189-95. PubMed ID: 8564588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Strontium-89 chloride (Metastron) for palliative treatment of bony metastases. The University of Minnesota experience.
    Lee CK; Aeppli DM; Unger J; Boudreau RJ; Levitt SH
    Am J Clin Oncol; 1996 Apr; 19(2):102-7. PubMed ID: 8610630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypocalcemia associated with strontium-89 administration in a patient with diffuse bone metastases from neuroendocrine carcinoma.
    Mori M; Fadul NA; Bruera E; Dalal S
    J Pain Symptom Manage; 2009 May; 37(5):923-9. PubMed ID: 19041217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Strontium-89 (Metastron) versus external beam radiotherapy in patients with painful bone metastases secondary to prostatic cancer: preliminary report of a multicenter trial. UK Metastron Investigators Group.
    Bolger JJ; Dearnaley DP; Kirk D; Lewington VJ; Mason MD; Quilty PM; Reed NS; Russell JM; Yardley J
    Semin Oncol; 1993 Jun; 20(3 Suppl 2):32-3. PubMed ID: 7684863
    [No Abstract]   [Full Text] [Related]  

  • 12. Strontium-89 for treatment of painful bone metastasis from prostate cancer.
    Altman GB; Lee CA
    Oncol Nurs Forum; 1996 Apr; 23(3):523-7. PubMed ID: 8801513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Internal strontium-89 radiotherapy for malignant bony metastasis].
    Lou C; Zhang D; Yu L
    Zhonghua Zhong Liu Za Zhi; 2001 Nov; 23(6):507-9. PubMed ID: 11859724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone pain palliation with strontium-89 in cancer patients with bone metastases.
    Giammarile F; Mognetti T; Resche I
    Q J Nucl Med; 2001 Mar; 45(1):78-83. PubMed ID: 11456379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radionuclide-targeted therapy for the management of metastatic bone pain.
    Ackery D; Yardley J
    Semin Oncol; 1993 Jun; 20(3 Suppl 2):27-31. PubMed ID: 7684862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Less pain does equal better quality of life following strontium-89 therapy for metastatic prostate cancer.
    Turner SL; Gruenewald S; Spry N; Gebski V;
    Br J Cancer; 2001 Feb; 84(3):297-302. PubMed ID: 11161391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical experience with strontium-89 in prostatic and breast cancer patients.
    Robinson RG; Preston DF; Baxter KG; Dusing RW; Spicer JA
    Semin Oncol; 1993 Jun; 20(3 Suppl 2):44-8. PubMed ID: 8503027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Strontium-89 for bone metastases from prostate cancer: an update].
    Zhao WW; Xie P; Deng HF
    Zhonghua Nan Ke Xue; 2010 Mar; 16(3):269-72. PubMed ID: 20369560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A retrospective analysis of the cost effectiveness of treatment with Metastron in patients with prostate cancer metastatic to bone.
    McEwan AJ; Amyotte GA; McGowan DG; MacGillivray JA; Porter AT
    Eur Urol; 1994; 26 Suppl 1():26-31. PubMed ID: 7537666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of radioisotopes for palliation of metastatic bone pain.
    Gkialas I; Iordanidou L; Galanakis I; Giannopoulos S
    J BUON; 2008; 13(2):177-83. PubMed ID: 18555462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.